TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive In Brief: Reynolds Retires “Joe Camel” advertising; Slaga Moves Lab To MC Cancer Center July 18, 1997
TCL Archive In Brief: FDA Changes Package Inserts For Thiotepa, Cyclophosphamide, As Committee Suggested August 31, 1979
